Streetbeat News

Earnings

NAAS

NaaS Technology's shares have declined following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 5:31 pm

AVTX

Avalo Therapeutics' shares dropped following the announcement of worse-than-expected fiscal year 2023 earnings per share results.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 5:28 pm

BCLI

Brainstorm Cell Therapeutics shares are trading higher following the announcement of their FY23 financial results.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 5:24 pm

PLSE

Pulse Biosciences' stock is trading lower following the announcement of its Q4 financial results and plans to initiate a rights offering of up to $60 million worth of units.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 5:24 pm

OUST

Ouster's stock is experiencing an increase in value due to positive momentum from its Q4 financial results. Additionally, Craig-Hallum has reaffirmed its Buy rating on the stock and increased the price target from $9 to $10.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 5:21 pm

GME

GameStop shares are trading lower due to potential ongoing weakness after reporting worse-than-expected Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 5:14 pm

SRZN

Surrozen Inc (NASDAQ:SRZN) announced a private placement for common stock and warrants, aiming to raise approximately $192.5 million if all warrants are exercised. The initial proceeds of about $17.5 million will support the SZN-043 clinical development for severe alcohol-associated hepatitis and other purposes. The funds, along with existing cash, are expected to cover expenses through the first half of 2025. Surrozen also updated on the Phase 1a trial of SZN-043, showing safety and potential efficacy. SRZN shares dropped 27.1% to $11.00.

Portfolio Pulse from Vandana Singh

April 01, 2024 | 5:14 pm

CPTN

Cepton shares surged following the announcement of their Q4 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 5:12 pm

BYDDY

TSLA

BYD Co. Ltd. reported a year-over-year increase in Q1 BEV sales but saw a decline from the previous quarter. Despite this, Tesla, Inc. is expected to report a year-over-year drop in deliveries for the first time since COVID-19, potentially allowing BYD to maintain its lead as the world's biggest battery EV manufacturer. Tesla's Q1 delivery estimates are lower than consensus, amid slowing EV adoption and intense competition.

Portfolio Pulse from Shanthi Rexaline

April 01, 2024 | 5:10 pm

AEON

AEON Biopharma shares are trading lower following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 5:09 pm